NCT04459273View on ClinicalTrials.gov

Prospective Exploratory Study of FAPi PET/CT With Histopathology Validation in Patients With Various Cancers

PHASE1Active, not recruitingINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

August 27, 2020

Primary Completion Date

July 1, 2026

Study Completion Date

July 1, 2027

Conditions
Bladder CarcinomaCervical CarcinomaCholangiocarcinomaHematopoietic and Lymphoid Cell NeoplasmHepatocellular CarcinomaMalignant Adrenal Gland NeoplasmMalignant Brain NeoplasmMalignant Pleural NeoplasmMalignant Skin NeoplasmMalignant Solid NeoplasmMalignant Testicular NeoplasmMalignant Thymus NeoplasmNeuroendocrine NeoplasmThyroid Gland CarcinomaUrothelial CarcinomaCancer of Unknown Primary Site
Interventions
PROCEDURE

Computed Tomography

Undergo PET/CT

DRUG

Gallium Ga 68 FAPi-46

Given IV

PROCEDURE

Positron Emission Tomography

Undergo PET/CT

RADIATION

18F-FDG

Given IV

Trial Locations (1)

90095

UCLA / Jonsson Comprehensive Cancer Center, Los Angeles

All Listed Sponsors
lead

Jonsson Comprehensive Cancer Center

OTHER